Clinical Trial Update: A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating changes in pigmentation and safety of afamelanotide in patients with vitiligo on the face.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Afamelanotide (afamelanotide)

Snippet

Sponsor: Clinuvel, Inc. | Conditions: Vitiligo | Phase 2 | Status: UNKNOWN